Libivirumab

From Self-sufficiency

Revision as of 16:10, 16 March 2010 by Anypodetos (Talk) (Added mab_type, updated source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Libivirumab
Monoclonal antibody
Type	Whole antibody
Source	Template:Infobox drug/mab source
Target	Hepatitis B surface antigen
Identifiers
CAS Number	569658-79-3
ATC code	none
Chemical data
Formula	C₆₅₉₈H₁₀₂₃₂N₁₇₈₈O₂₀₆₀S₄₆
Molar mass	149.04 kDa[[Script error: No such module "String".]]

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.^[1]^[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

v t e Human monoclonal antibodies ("-u-")
"-limu-" (immune system)	immunosuppression: Adalimumab, Atorolimumab, Fresolimumab, Golimumab, Lerdelimumab, Metelimumab, Morolimumab immune activation: Ipilimumab, Tremelimumab other: Bertilimumab, Zanolimumab
"-kinu-" (interleukin as target)	Briakinumab, Canakinumab, Ustekinumab
"-tumu-"/"-tu-" (tumor)	Adecatumumab, Belimumab, Cixutumumab, Conatumumab, Figitumumab, Iratumumab, Lexatumumab, Lucatumumab, Mapatumumab, Necitumumab, Ofatumumab, Olaratumab, Panitumumab, Pritumumab, Robatumumab, Votumumab, Zalutumumab
"-osu-" (bone)	Denosumab
"-mulu-" (musculoskeletal)	Stamulumab^†
"-fungu-" (fungal)	Efungumab
"-viru-" (viral)	Exbivirumab, Foravirumab, Libivirumab, Rafivirumab, Regavirumab, Sevirumab, Tuvirumab
"-bacu-" (bacterial)	Nebacumab, Panobacumab, Raxibacumab
"-ciru-" (cardiovascular)	Ramucirumab
"-neru-" (neurologic)	Gantenerumab
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This monoclonal antibody-related article is a stub. You can help ssf by expanding it.

↑ WHO Drug Information
↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.